Failure of monoclonal antibodies against CGRP or its receptor does not imply lack of efficacy of other drugs from the same class

Publication date: Available online 8 July 2021Source: Neurología (English Edition)Author(s): J. Porta-Etessam, N. González-García, Á.L. Guerrero, D. García-Azorín
Source: Neurologia - Category: Neurology Source Type: research
More News: Brain | Neurology